These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25853905)

  • 1. Intraventricular fibrinolysis with tissue plasminogen activator is associated with transient cerebrospinal fluid inflammation: a randomized controlled trial.
    Kramer AH; Jenne CN; Zygun DA; Roberts DJ; Hill MD; Holodinsky JK; Todd S; Kubes P; Wong JH
    J Cereb Blood Flow Metab; 2015 Aug; 35(8):1241-8. PubMed ID: 25853905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and Pharmacodynamics of Tissue Plasminogen Activator Administered Through an External Ventricular Drain.
    Kramer AH; Jenne C; Holodinsky JK; Todd S; Roberts DJ; Kubes P; Zygun DA; Hill MD; Leger C; Wong JH
    Neurocrit Care; 2015 Dec; 23(3):386-93. PubMed ID: 25739904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urokinase versus Alteplase for intraventricular hemorrhage fibrinolysis.
    Gaberel T; Montagne A; Lesept F; Gauberti M; Lemarchand E; Orset C; Goulay R; Bertrand T; Emery E; Vivien D
    Neuropharmacology; 2014 Oct; 85():158-65. PubMed ID: 24846802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of combined intraventricular fibrinolysis with lumbar drainage for prevention of permanent shunt dependency after intracerebral hemorrhage with severe ventricular involvement: A randomized trial and individual patient data meta-analysis.
    Staykov D; Kuramatsu JB; Bardutzky J; Volbers B; Gerner ST; Kloska SP; Doerfler A; Schwab S; Huttner HB
    Ann Neurol; 2017 Jan; 81(1):93-103. PubMed ID: 27888608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraventricular tissue plasminogen activator in subarachnoid hemorrhage patients: a prospective, randomized, placebo-controlled pilot trial.
    Kramer AH; Roberts DJ; Holodinsky J; Todd S; Hill MD; Zygun DA; Faris P; Wong JH
    Neurocrit Care; 2014 Oct; 21(2):275-84. PubMed ID: 24627207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No exacerbation of perihematomal edema with intraventricular tissue plasminogen activator in patients with spontaneous intraventricular hemorrhage.
    Ziai W; Moullaali T; Nekoovaght-Tak S; Ullman N; Brooks JS; Morgan TC; Hanley DF
    Neurocrit Care; 2013 Jun; 18(3):354-61. PubMed ID: 23463422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single versus bilateral external ventricular drainage for intraventricular fibrinolysis using urokinase in severe ventricular haemorrhage.
    Du B; Wang J; Zhong XL; Liang J; Xiang W; Chen D; Lv W; Shan AJ
    Brain Inj; 2014; 28(11):1413-6. PubMed ID: 24830742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous Intraventricular Hemorrhage: When Should Intraventricular tPA Be Considered?
    Abdelmalik PA; Ziai WC
    Semin Respir Crit Care Med; 2017 Dec; 38(6):745-759. PubMed ID: 29262432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular dilatation in experimental intraventricular hemorrhage in pigs. Characterization of cerebrospinal fluid dynamics and the effects of fibrinolytic treatment.
    Mayfrank L; Kissler J; Raoofi R; Delsing P; Weis J; Küker W; Gilsbach JM
    Stroke; 1997 Jan; 28(1):141-8. PubMed ID: 8996503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological changes following experimental intraventricular haemorrhage and intraventricular fibrinolytic treatment with recombinant tissue plasminogen activator.
    Mayfrank L; Kim Y; Kissler J; Delsing P; Gilsbach JM; Schröder JM; Weis J
    Acta Neuropathol; 2000 Nov; 100(5):561-7. PubMed ID: 11045679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis.
    van Veen SQ; Meijers JC; Levi M; van Gulik TM; Boermeester MA
    Shock; 2007 May; 27(5):534-41. PubMed ID: 17438459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue plasminogen activator for the treatment of intraventricular hematoma: the dose-effect relationship.
    Wang YC; Lin CW; Shen CC; Lai SC; Kuo JS
    J Neurol Sci; 2002 Oct; 202(1-2):35-41. PubMed ID: 12220690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trial.
    Murthy SB; Awad I; Harnof S; Aldrich F; Harrigan M; Jallo J; Caron JL; Huang J; Camarata P; Lara LR; Dlugash R; McBee N; Eslami V; Hanley DF; Ziai WC;
    Neurology; 2017 Jul; 89(4):355-362. PubMed ID: 28659429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraventricular streptokinase increases cerebrospinal fluid D dimer in preterm infants with posthaemorrhagic ventricular dilatation.
    Whitelaw A; Mowinckel MC; Larsen ML; Røkås E; Abildgaard U
    Acta Paediatr; 1994 Mar; 83(3):270-2. PubMed ID: 8038528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraventricular hemorrhage after aneurysmal subarachnoid hemorrhage: pilot study of treatment with intraventricular tissue plasminogen activator.
    Varelas PN; Rickert KL; Cusick J; Hacein-Bey L; Sinson G; Torbey M; Spanaki M; Gennarelli TA
    Neurosurgery; 2005 Feb; 56(2):205-13; discussion 205-13. PubMed ID: 15670368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower dose intraventricular T-PA fibrinolysis: case report.
    Deutsch H; Rodriguez JC; Titton RL
    Surg Neurol; 2004 May; 61(5):460-3; discussion 463. PubMed ID: 15120223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low levels of plasminogen in cerebrospinal fluid after intraventricular haemorrhage: a limiting factor for clot lysis?
    Whitelaw A; Mowinckel MC; Abildgaard U
    Acta Paediatr; 1995 Aug; 84(8):933-6. PubMed ID: 7488820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exacerbation of perihematomal edema and sterile meningitis with intraventricular administration of tissue plasminogen activator in patients with intracerebral hemorrhage.
    Ducruet AF; Hickman ZL; Zacharia BE; Grobelny BT; Narula R; Guo KH; Claassen J; Lee K; Badjatia N; Mayer SA; Connolly ES
    Neurosurgery; 2010 Apr; 66(4):648-55. PubMed ID: 20305489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective, randomized, open-label phase II trial on concomitant intraventricular fibrinolysis and low-frequency rotation after severe subarachnoid hemorrhage.
    Etminan N; Beseoglu K; Eicker SO; Turowski B; Steiger HJ; Hänggi D
    Stroke; 2013 Aug; 44(8):2162-8. PubMed ID: 23735957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombolytic therapy after intraventricular haemorrhage].
    Gadegaard KH; Dahl BL; Hansen TS
    Ugeskr Laeger; 2010 May; 172(19):1440-1. PubMed ID: 20470653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.